L'Oréal - 2018 Registration Document

4 2018 Consolidated Financial Statements NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

€ millions 2016

31.12.2015 Acquisitions/Disposals

Other movements

31.12.2016

L’Oréal Professionnel/Kérastase

388.4 426.3 565.4 137.4

2.7

6.7 9.9

397.9 436.2 585.6 137.4

Matrix

Redken/PureOlogy Decléor and Carita

4.8

15.4

Others

3.3

0.1

3.4

Professional Products Total

1,520.8

7.5

32.1 61.8 76.6

1,560.4

L’Oréal Paris

795.0

13.6

870.5

Maybelline/Garnier

1,215.1

1,291.7

Magic Holdings

453.9 158.3 336.1 232.2 180.7 803.0 133.0 519.8 334.8 311.9 156.7

-179.9

274.0 158.3 345.1 180.3 186.8 800.3 141.7 519.8 447.8

LaSCAD

NYX Professional Makeup

0.1

9.0

Niely

-51.9

Others

6.1

Consumer Products Total

3,371.3

13.7

-78.3

3,306.7

Lancôme

-2.7

Shu Uemura YSL Beauté

8.7

Perfumes

112.9

L’Oréal Beauty Device (1)

-238.0

73.9

Urban Decay IT Cosmetics

4.4

161.1 812.4

-

779.5

32.9

Others

65.4

0.3

65.6

L’Oréal Luxe Total Vichy/Dermablend

2,324.6

892.4

-194.5

3,022.6

283.3 121.7 405.0

2.2 2.1 4.3 3.9

285.5 123.8 409.2

Others

Active Cosmetics Total

-

Others

80.0

83.9

The Body Shop GROUP TOTAL

449.9

-

-40.0

409.8

8,151.5

913.6

-272.5

8,792.5

This Cash Generating Unit mainly concerns Clarisonic. (1)

2016 acquisitions mainly relate to IT Cosmetics, Atelier Cologne, the Thermes Saint-Gervais and the American distributor Raylon for €913.6 million. Goodwill amounting to €232.2 million and resulting from the acquisition of Niely was allocated to the L’Oréal Paris CGU for €51.6 million and to the Maybelline/Garnier CGU for €45.1 million, based on expected synergies. No significant disposals took place during 2016.

Other movements mainly reflect the positive impact of changes in exchange rates for €117.4 million, as well as the recognition of impairment losses against L’Oréal Beauty Device (€235.6 million) and against Magic (€162.7 million) (note 7.3.). The accumulated impairment losses relating to L’Oréal Beauty Device, Magic, Softsheen-Carson, Yue-Sai and Sanoflore amounted to €246.3 million, €163.1 million, €158.8 million, €33.1 million and €35.7 million respectively at 31 December 2016.

REGISTRATION DOCUMENT / L'ORÉAL 2018

270